United States of America based
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
TechnologiesAI Companies (Drug Discovery)
No pipelines published yet
No services posted yet